133 related articles for article (PubMed ID: 23884964)
1. CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus.
Scerif M; Füzesi T; Thomas JD; Kola B; Grossman AB; Fekete C; Korbonits M
J Endocrinol; 2013 Oct; 219(1):79-88. PubMed ID: 23884964
[TBL] [Abstract][Full Text] [Related]
2. AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome.
Christ-Crain M; Kola B; Lolli F; Fekete C; Seboek D; Wittmann G; Feltrin D; Igreja SC; Ajodha S; Harvey-White J; Kunos G; Müller B; Pralong F; Aubert G; Arnaldi G; Giacchetti G; Boscaro M; Grossman AB; Korbonits M
FASEB J; 2008 Jun; 22(6):1672-83. PubMed ID: 18198220
[TBL] [Abstract][Full Text] [Related]
3. The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release.
Kola B; Wittman G; Bodnár I; Amin F; Lim CT; Oláh M; Christ-Crain M; Lolli F; van Thuijl H; Leontiou CA; Füzesi T; Dalino P; Isidori AM; Harvey-White J; Kunos G; Nagy GM; Grossman AB; Fekete C; Korbonits M
FASEB J; 2013 Dec; 27(12):5112-21. PubMed ID: 23982145
[TBL] [Abstract][Full Text] [Related]
4. A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome.
Bowles NP; Karatsoreos IN; Li X; Vemuri VK; Wood JA; Li Z; Tamashiro KL; Schwartz GJ; Makriyannis AM; Kunos G; Hillard CJ; McEwen BS; Hill MN
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):285-90. PubMed ID: 25535367
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism.
Lim CT; Kola B; Feltrin D; Perez-Tilve D; Tschöp MH; Grossman AB; Korbonits M
Mol Cell Endocrinol; 2013 Jan; 365(2):303-8. PubMed ID: 23178796
[TBL] [Abstract][Full Text] [Related]
6. Fructose-induced hypothalamic AMPK activation stimulates hepatic PEPCK and gluconeogenesis due to increased corticosterone levels.
Kinote A; Faria JA; Roman EA; Solon C; Razolli DS; Ignacio-Souza LM; Sollon CS; Nascimento LF; de Araújo TM; Barbosa AP; Lellis-Santos C; Velloso LA; Bordin S; Anhê GF
Endocrinology; 2012 Aug; 153(8):3633-45. PubMed ID: 22585831
[TBL] [Abstract][Full Text] [Related]
7. Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?
Kunos G
Am J Med; 2007 Sep; 120(9 Suppl 1):S18-24; discussion S24. PubMed ID: 17720356
[TBL] [Abstract][Full Text] [Related]
8. The role of the endocannabinoid system in the control of energy homeostasis.
Osei-Hyiaman D; Harvey-White J; Bátkai S; Kunos G
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S33-8. PubMed ID: 16570103
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice.
Liao Y; Bin J; Asakura M; Xuan W; Chen B; Huang Q; Xu D; Ledent C; Takashima S; Kitakaze M
Eur Heart J; 2012 Dec; 33(24):3124-33. PubMed ID: 21785110
[TBL] [Abstract][Full Text] [Related]
10. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system.
Kola B; Farkas I; Christ-Crain M; Wittmann G; Lolli F; Amin F; Harvey-White J; Liposits Z; Kunos G; Grossman AB; Fekete C; Korbonits M
PLoS One; 2008 Mar; 3(3):e1797. PubMed ID: 18335063
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase.
Kola B; Hubina E; Tucci SA; Kirkham TC; Garcia EA; Mitchell SE; Williams LM; Hawley SA; Hardie DG; Grossman AB; Korbonits M
J Biol Chem; 2005 Jul; 280(26):25196-201. PubMed ID: 15899896
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of dyslipidemia in Cushing's syndrome.
Arnaldi G; Scandali VM; Trementino L; Cardinaletti M; Appolloni G; Boscaro M
Neuroendocrinology; 2010; 92 Suppl 1():86-90. PubMed ID: 20829625
[TBL] [Abstract][Full Text] [Related]
13. Effect of dexamethasone on gene expression of cannabinoid receptor type 1 and adenosine monophosphate-activated protein kinase in the hypothalamus of broilers (Gallus domesticus).
Kong L; Xiao C; Lin H; Buyse J; Li X; Song Z
Comp Biochem Physiol A Mol Integr Physiol; 2021 Oct; 260():111018. PubMed ID: 34144188
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids increase NPY gene expression via hypothalamic AMPK signaling in broiler chicks.
Liu L; Song Z; Jiao H; Lin H
Endocrinology; 2014 Jun; 155(6):2190-8. PubMed ID: 24693963
[TBL] [Abstract][Full Text] [Related]
15. Modifications in basal and stress-induced hypothalamic AMP-activated protein kinase (AMPK) activity in rats chronically treated with an angiotensin II receptor blocker.
Marques MB; Ribeiro-Oliveira A; Guimarães J; Nascimento GF; Anjos AP; Vilas-Boas WW; Santos RA; Thomas JD; Igreja SM; Grossman AB; Kola B; Korbonits M
Stress; 2012 Sep; 15(5):554-61. PubMed ID: 22217206
[TBL] [Abstract][Full Text] [Related]
16. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.
Cota D; Marsicano G; Tschöp M; Grübler Y; Flachskamm C; Schubert M; Auer D; Yassouridis A; Thöne-Reineke C; Ortmann S; Tomassoni F; Cervino C; Nisoli E; Linthorst AC; Pasquali R; Lutz B; Stalla GK; Pagotto U
J Clin Invest; 2003 Aug; 112(3):423-31. PubMed ID: 12897210
[TBL] [Abstract][Full Text] [Related]
17. Appetite and metabolic effects of ghrelin and cannabinoids: involvement of AMP-activated protein kinase.
van Thuijl H; Kola B; Korbonits M
Vitam Horm; 2008; 77():121-48. PubMed ID: 17983855
[TBL] [Abstract][Full Text] [Related]
18. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
Burmeister MA; Ayala J; Drucker DJ; Ayala JE
Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495
[TBL] [Abstract][Full Text] [Related]
19. Distribution of type 1 cannabinoid receptor (CB1)-immunoreactive axons in the mouse hypothalamus.
Wittmann G; Deli L; Kalló I; Hrabovszky E; Watanabe M; Liposits Z; Fekete C
J Comp Neurol; 2007 Jul; 503(2):270-9. PubMed ID: 17492633
[TBL] [Abstract][Full Text] [Related]
20. Citrate diminishes hypothalamic acetyl-CoA carboxylase phosphorylation and modulates satiety signals and hepatic mechanisms involved in glucose homeostasis in rats.
Cesquini M; Stoppa GR; Prada PO; Torsoni AS; Romanatto T; Souza A; Saad MJ; Velloso LA; Torsoni MA
Life Sci; 2008 Jun; 82(25-26):1262-71. PubMed ID: 18534630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
